In this article, we will discuss Mycophenolate (Indications). So, let’s get started.
Renal, Cardiac, and Hepatic Transplant
Mycophenolate is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Mycophenolate should be used concomitantly with cyclosporine and corticosteroids. Mycophenolate Intravenous is an alternative dosage form to Mycophenolate capsules, tablets and oral suspension. Mycophenolate Intravenous should be administered within 24 hours following transplantation. Mycophenolate Intravenous can be administered for up to 14 days; patients should be switched to oral Mycophenolate as soon as they can tolerate oral medication.